X

Trial Profile

Randomized Study Comparing Induction Chemotherapy With Docetaxel, Cisplatin, 5FU [fluorouracil] Versus Cisplatin, 5 FU in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 20 Feb 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil
Indications Carcinoma; Head and neck cancer; Laryngeal cancer
Focus Registrational; Therapeutic Use

Most Recent Events

28 Oct 2015 Results of a long term follow up published in the Journal of the National Cancer Institute
02 Jun 2015 Results of long term follow up (5 and 10 years) presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
12 Oct 2009 Long-term quality-of-life data have been presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com